Cero Therapeutics Holdings Files 8-K
Ticker: CEROW · Form: 8-K · Filed: Jun 11, 2025 · CIK: 1870404
Sentiment: neutral
Topics: corporate-filing, amendment, company-name-change
Related Tickers: CERO
TL;DR
Cero Therapeutics filed an 8-K on 6/11/25, watch for corporate changes.
AI Summary
Cero Therapeutics Holdings, Inc. filed an 8-K on June 11, 2025, reporting amendments to its articles of incorporation or bylaws, other events, and financial statements/exhibits. The company, formerly known as Phoenix Biotech Acquisition Corp. until June 30, 2021, is incorporated in Delaware and operates in the biological products sector.
Why It Matters
This filing indicates potential corporate structure changes or significant events for Cero Therapeutics, which could impact its operational direction and investor outlook.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not contain information suggesting immediate financial distress or significant negative events.
Key Players & Entities
- CERO THERAPEUTICS HOLDINGS, INC. (company) — Registrant
- Phoenix Biotech Acquisition Corp. (company) — Former company name
- June 11, 2025 (date) — Date of earliest event reported
- June 30, 2021 (date) — Date of name change
FAQ
What specific amendments were made to Cero Therapeutics Holdings, Inc.'s articles of incorporation or bylaws?
The filing indicates amendments were made, but the specific details of these amendments are not provided in the provided text.
What are the 'Other Events' reported by Cero Therapeutics Holdings, Inc. on June 11, 2025?
The specific nature of the 'Other Events' is not detailed in the provided excerpt of the 8-K filing.
What is the SIC code for Cero Therapeutics Holdings, Inc. and what does it represent?
The SIC code is 2836, which represents Biological Products (No Diagnostic Substances).
When did Cero Therapeutics Holdings, Inc. change its name from Phoenix Biotech Acquisition Corp.?
The company changed its name on June 30, 2021.
What is the business address of Cero Therapeutics Holdings, Inc.?
The business address is 201 Haskins Way, Suite 230, South San Francisco, CA 94080.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 11, 2025 regarding CERO THERAPEUTICS HOLDINGS, INC. (CEROW).